These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6975958)

  • 1. Suppression of milk drinking by the combination of fluoxetine and L-5-hydroxytryptophan in rats.
    Fuller RW; Owen JE
    Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):137-40. PubMed ID: 6975958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of the L-5-hydroxytryptophan-induced elevation of plasma corticosterone levels in rats by a specific inhibitor of serotonin uptake.
    Fuller RW; Snoddy HD; Molloy BB
    Res Commun Chem Pathol Pharmacol; 1975 Jan; 10(1):193-6. PubMed ID: 1079087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of 3,4-dihydroxyphenylacetic acid concentration by L-5-hydroxytryptophan in control and fluoxetine-pretreated rats.
    Fuller RW; Perry KW
    J Pharm Pharmacol; 1981 Jun; 33(6):406-7. PubMed ID: 6115023
    [No Abstract]   [Full Text] [Related]  

  • 4. Antihypertensive effects of fluoxetine and L-5-hydroxytryptophan in rats.
    Fuller RW; Holland DR; Yen TT; Bemis KG; Stamm NB
    Life Sci; 1979 Oct; 25(14):1237-42. PubMed ID: 316092
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of chronic fluoxetine administration on serotonin metabolism.
    Hwang EC; Magnussen I; Van Woert MH
    Res Commun Chem Pathol Pharmacol; 1980 Jul; 29(1):79-98. PubMed ID: 6157184
    [No Abstract]   [Full Text] [Related]  

  • 6. Functional consequences of inhibiting serotonin uptake with fluoxetine in rats.
    Fuller RW
    Adv Biochem Psychopharmacol; 1982; 34():219-28. PubMed ID: 6753512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of brain serotonin alterations on hypothermia produced by chlorpromazine in rats.
    Lin MT; Chern YF; Chow CF; Li YP
    Pharmacology; 1979; 18(3):128-35. PubMed ID: 156373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of REM sleep by fluoxetine, a specific inhibitor of serotonin uptake.
    Slater IH; Jones GT; Moore RA
    Neuropharmacology; 1978 Jun; 17(6):383-9. PubMed ID: 209365
    [No Abstract]   [Full Text] [Related]  

  • 9. The acute effects of 5HTP, fluoxetine and quipazine on insulin and glucagon release in the intact rat.
    Jacoby JH; Bryce GF
    Horm Metab Res; 1979 Feb; 11(2):90-4. PubMed ID: 312241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Lilly 110140, a specific inhibitor of 5-hydroxytryptamine uptake, on food intake and on 5-hydroxytryptophan-induced anorexia. Evidence for serotoninergic inhibition of feeding.
    Goudie AJ; Thornton EW; Wheeler TJ
    J Pharm Pharmacol; 1976 Apr; 28(4):318-20. PubMed ID: 6727
    [No Abstract]   [Full Text] [Related]  

  • 11. Serotonin regulation of corticoid secretion in infant rats.
    Grota LJ
    Dev Psychobiol; 1981 May; 14(3):221-8. PubMed ID: 6973496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular 5-hydroxytryptamine concentration in rat hypothalamus after administration of fluoxetine plus L-5-hydroxytryptophan.
    Perry KW; Fuller RW
    J Pharm Pharmacol; 1993 Aug; 45(8):759-61. PubMed ID: 7901377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the chronic ingestion of therapeutic doses of chlorimipramine on the behavioral action of agonists and antagonists of serotonin in male rats.
    Rodríguez Echandía EL; Broitman ST; Fóscolo MR
    Pharmacol Biochem Behav; 1983 Aug; 19(2):193-7. PubMed ID: 6605538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of central and peripheral pretreatment with fluoxetine in gustatory conditioning.
    Lorden JF; Nunn WB
    Pharmacol Biochem Behav; 1982 Sep; 17(3):435-43. PubMed ID: 6292958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inability of chronic fluoxetine to potentiate a serotonin mediated effect.
    Sugrue MF
    Commun Psychopharmacol; 1980; 4(2):131-4. PubMed ID: 6968660
    [No Abstract]   [Full Text] [Related]  

  • 16. Absolute configurations and pharmacological activities of the optical isomers of fluoxetine, a selective serotonin-uptake inhibitor.
    Robertson DW; Krushinski JH; Fuller RW; Leander JD
    J Med Chem; 1988 Jul; 31(7):1412-7. PubMed ID: 3260286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term infusion of L-5-hydroxytryptophan increases brain serotonin turnover and decreases blood pressure in normotensive rats.
    Echizen H; Freed CR
    J Pharmacol Exp Ther; 1982 Mar; 220(3):579-84. PubMed ID: 6977639
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of naloxone on the secretion of prolactin and corticosterone induced by 5-hydroxytryptophan and a serotonergic agonist, mCPP.
    Preziosi P; Cerrito F; Vacca M
    Life Sci; 1983 May; 32(21):2423-30. PubMed ID: 6602260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological evidence for the existence of multiple functional pools of brain serotonin: analysis of brain perfusate from conscious rats.
    Kleven MS; Dwoskin LP; Sparber SB
    J Neurochem; 1983 Oct; 41(4):1143-9. PubMed ID: 6194257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of serotonin in the anticonvulsant effect of fluoxetine in genetically epilepsy-prone rats.
    Yan QS; Jobe PC; Cheong JH; Ko KH; Dailey JW
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Aug; 350(2):149-52. PubMed ID: 7527501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.